Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004609305 | SCV005104778 | pathogenic | Inborn genetic diseases | 2024-06-18 | criteria provided, single submitter | clinical testing | The c.3999C>A (p.C1333*) alteration, located in exon 27 (coding exon 27) of the CUBN gene, consists of a C to A substitution at nucleotide position 3999. This changes the amino acid from a cysteine (C) to a stop codon at amino acid position 1333. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the available evidence, this alteration is classified as pathogenic. |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000049750 | SCV000082157 | probable-pathogenic | Imerslund-Grasbeck syndrome | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |